Impedans: Funding, Investors & Team (Sep 2026)
Impedans furnish you with astute detecting stages for radio-recurrence (RF) and plasma process checking. Their items find applications in central exploration, process advancement, device configuration, process control and issue identification and order (FDC). They serve a large number of ventures, because of the omnipresent idea of RF and plasma handling, for example, semiconductor, vacuum covering, clinical gadget, hard circle and aviation among numerous others. Their offer is that They give you an autonomous finding of your cycle wellbeing, utilizing wise, web empowered detecting stages, related to their tremendous involvement with RF and plasma frameworks, to assist you with settling the most perplexing handling issues.
Impedans has raised $3.6M across 1 funding round on record, the most recent a Series B of $3.6M announced in Jul 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Impedans Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Impedans Funding Rounds
Impedans Founders and Leadership Team
No contact details are on record for this team yet.
Impedans Funding Compared to Other Biotechnology Startups
Impedans' latest round of $3.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Impedans in Biotechnology and Dublin
Companies Similar to Impedans
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate…
Antler Bio employs gene expression data to assist in herd management and provides services for analyzing…
Nemysis unique strategy is a staged approach to the development of OTC and Prescription Products, tackling…
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the…
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are…
Relevium Medical is a biopharmaceutical company with offices in both Ireland and the US that aims to enhance…
Ovagen Group Limited is a veterinary company based out of Ballina, Mayo, Ireland.
SOMAÍ is committed to building a strong global brand offering innovative cannabis-based therapeutics, aimed…
Beyondbmi offers specialized doctors and nutritionists who focus on managing weight, as well as the most…
Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara…
Medical device company developing a closure device for vascular access procedures.
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target…
Impedans Funding FAQs
What does Impedans do?
Impedans furnish you with astute detecting stages for radio-recurrence (RF) and plasma process checking. Their items find applications in central exploration, process advancement, device configuration, process control and issue identification and order (FDC). They serve a large number of ventures, because of the omnipresent idea of RF and plasma handling, for example, semiconductor, vacuum covering, clinical gadget, hard circle and aviation among numerous others. Their offer is that They give you an autonomous finding of your cycle wellbeing, utilizing wise, web empowered detecting stages, related to their tremendous involvement with RF and plasma frameworks, to assist you with settling the most perplexing handling issues.
How much funding has Impedans raised?
Impedans has raised $3.6M across 1 round on record. The most recent is a Series B of $3.6M announced in Jul 2022.
When did Impedans last raise funding?
Impedans' most recent funding round on record is a Series B of $3.6M, announced in Jul 2022.
Who is the CEO of Impedans?
Mike Hopkins is listed as CEO at Impedans.
Where is Impedans headquartered?
Impedans is based in Dublin, Ireland.
How many employees does Impedans have?
Impedans is in the 11-50 employee band.
How does Impedans' funding compare to other Biotechnology startups?
Impedans' latest round of $3.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Impedans Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Impedans is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.